Drug testing and urinalysis specimen collection services

The Oregon Health Authority (OHA) and Oregon State Hospital (OSH) are seeking a qualified contractor to provide comprehensive drug testing and urinalysis specimen collection services for pre-employment and reasonable suspicion testing at their Junction City and Salem hospital campuses. The Request for Proposal (RFP #S-44300-00012831) requires an accredited provider capable of conducting 8-panel urinalysis screenings that test for substances including amphetamines, cocaine, morphine/hydrocodone, phencyclidine, MDMA, 6-acetylmorphone, oxycodone/oxymorphone, and marijuana. The contract will initially span three years with potential renewal options up to five years, with proposals due on May 27, 2025, at 3 PM. Evaluation will be comprehensive, totaling 100 possible points across four key areas: Qualifications (25 points), Drug Testing Services (25 points), Collection Sites and Services (10 points), Laboratory Testing Services (25 points), and Cost (15 points). The successful proposer must demonstrate appropriate licensing, maintain strict confidentiality protocols, and follow specific collection and testing procedures for employee and contracted staff screening.

The procurement includes specific provisions for disadvantaged business participation, requiring proposers to complete a Certified Disadvantaged Business Outreach Plan that addresses opportunities for minority-owned, woman-owned, service-disabled veteran-owned, and emerging small businesses certified by the Oregon Certification Office for Business Inclusion and Diversity (COBID). Proposers must detail potential subcontracting opportunities and demonstrate steps to solicit Certified Firms. Additional compliance requirements include non-discrimination attestations, Oregon tax law adherence, wage regulation compliance, and verification that the proposer is not on any government exclusion lists. While specific budget ranges are not explicitly stated, the contract will involve 24/7, 365-day testing services across two campuses, with options for expanded testing panels including additional substances like barbiturates, benzodiazepines, fentanyl, and synthetic cannabinoids. Proposers must also complete a Responsibility Inquiry form demonstrating financial stability, legal compliance, and operational capability, with additional requirements for larger firms including a Pay Equity Certificate for contracts exceeding $500,000.